• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Nat Commun . MELK inhibition disrupts actin cytoskeleton and broadly restricts human coronavirus infections

tetano

Editor, Senior Moderator
Nat Commun


. 2026 May 6.
doi: 10.1038/s41467-026-72615-1. Online ahead of print.
MELK inhibition disrupts actin cytoskeleton and broadly restricts human coronavirus infections

Kuai Yu[SUP] #[/SUP][SUP] 1 [/SUP], Qiaorui Yao[SUP] #[/SUP][SUP] 1 2 [/SUP], Dong Wang[SUP] #[/SUP][SUP] 1 3 [/SUP], Qingtao Hu[SUP] #[/SUP][SUP] 1 3 [/SUP], Dandan Li[SUP] #[/SUP][SUP] 1 [/SUP], Fang Li[SUP] 1 [/SUP], Fenghua Chen[SUP] 1 [/SUP], Jingyi Su[SUP] 1 [/SUP], Ting Huang[SUP] 1 [/SUP], Qing Zhang[SUP] 4 [/SUP], Zishuo Lin[SUP] 5 [/SUP], Wei Ran[SUP] 1 [/SUP], Yiliang Wang[SUP] 1 [/SUP], Yuzheng Zhou[SUP] 6 [/SUP], Shuai Wen[SUP] 1 [/SUP], Yuting Lin[SUP] 1 [/SUP], Yaming Jiu[SUP] 7 8 [/SUP], Jingxian Zhao[SUP] 9 10 [/SUP], Jincun Zhao[SUP] 11 12 13 14 [/SUP]


Affiliations
Abstract

Protein kinases regulate numerous critical biological processes in eukaryotic cells and are important targets for drug development. However, the common functional protein kinases and corresponding inhibitors with broad-spectrum therapeutic potential for human coronavirus infections remain largely unknown. By integrating global phosphoproteomics and high-content screening, we identify maternal embryonic leucine zipper kinase (MELK) as a common kinase required for the infections of multiple human coronaviruses currently circulating in the population. Inhibition of MELK activity by OTSSP167, or genetic depletion of its expression, exhibits broad antiviral effects in cells, human airway organoids as well as in mice under a prophylactic setting. Intriguingly, super-resolution imaging reveals that MELK colocalizes with the cellular actin cytoskeleton that is required for viral infection. Subsequently, live-cell imaging demonstrates that OTSSP167 treatment disrupts the dynamics of actin cytoskeleton. Mechanistic analysis reveals that MELK directly phosphorylates a key actin-depolymerizing protein, cofilin-1 at S3 and T70, thereby suppressing its actin-severing activity. Inhibiting MELK activity or expression activates cofilin-1 and disrupts actin filament formation, thereby impeding multiple steps of viral life cycle. Collectively, our study reveals a common regulation of coronavirus infections by MELK through modulation of actin cytoskeleton, and the broad antiviral effect of OTSSP167 as a novel actin cytoskeleton modulator.


 
Back
Top